Delivery Order SPE2DX22D0010-SPE2D825FJP43
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,284.14, is for the delivery of AZSTARYS CAPS 39.2MG/7.8MG, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 12, 2025. The contract has no set-aside designation, indicating open...
- This is a $1,797.13 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AZSTARYS 52.3 MG-10.4 MG CAP 100S, a pharmaceutical product, with a performance period ending on May 22, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,277.09, is for the provision of AZSTARYS CAPS 52.3MG/10.4MG, a pharmaceutical product. The award has an ultimate completion date of January 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
- This is a $1,304.01 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product, with a performance period ending on February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,921.48 to AmerisourceBergen Drug Corp for 100 capsules of AZSTARYS 26.1 mg-5.2 mg, a prescription medication. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 9, 2025. This delivery order represents a child contract under...
- This is a $1,150.76 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract is for the supply of the pharmaceutical product AZSTARYS 39.2 MG-7.8 MG CAP 100S. The contract was awarded on July 19, 2024 and has a completion date of July 22, 2024. The contract is a Firm Fixed Price type and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, leverages its extensive supply...
- The Defense Logistics Agency awarded a $5,531.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Azstarys 26.1 mg–5.2 mg capsules (100 count). This is a non-set-aside competitive award with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support...
- This federal contract award, valued at $1,259.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication AZSTARYS 39.2 MG-7.8 MG CAP 100S, with a completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,148.68 and is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies, including...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,034.80 by the Defense Logistics Agency (DLA) on September 9, 2025, with completion expected by September 10, 2025. The contract, issued under a firm fixed-price arrangement with no set-aside designation, calls for the delivery of Azstarys 39.2 mg-7.8 mg capsules (100-count units), a prescription medication used to treat...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJP43Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,844.76 to AmerisourceBergen Drug Corp for AZSTARYS CAPS 39.2MG/7.8MG on September 23, 2025, with completion expected by September 24, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement requirements. The award was placed of performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare systems and other federal healthcare organizations worldwide. AmerisourceBergen's extensive federal contracting portfolio and proven capability to compete successfully across multiple therapeutic domains—including specialty pharmaceuticals, vaccines, and medical devices—positions the company as a critical vendor within the Defense Health Agency's medical supply infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 9/23/25 |